Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.3
(3.45%)
AUD 0.3
(3.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 15.89 Million AUD | 208.93% |
| 2023 | 5.14 Million AUD | 100.79% |
| 2022 | 2.56 Million AUD | 117.54% |
| 2021 | 1.17 Million AUD | 26.44% |
| 2020 | 931.52 Thousand AUD | -29.84% |
| 2019 | 1.32 Million AUD | 195.84% |
| 2018 | 448.82 Thousand AUD | -48.67% |
| 2017 | 874.44 Thousand AUD | 322.85% |
| 2016 | 206.79 Thousand AUD | -24.1% |
| 2015 | 272.47 Thousand AUD | 33.69% |
| 2014 | 203.8 Thousand AUD | 31.86% |
| 2013 | 154.56 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 15.89 Million AUD | 0.0% |
| 2024 FY | 15.89 Million AUD | 208.93% |
| 2024 Q2 | 4.93 Million AUD | 0.0% |
| 2023 Q4 | 5.14 Million AUD | 0.0% |
| 2023 FY | 5.14 Million AUD | 100.79% |
| 2023 Q2 | 1.4 Million AUD | 0.0% |
| 2022 Q2 | 1.24 Million AUD | 0.0% |
| 2022 FY | 2.56 Million AUD | 117.54% |
| 2022 Q4 | 2.56 Million AUD | 0.0% |
| 2021 Q4 | 1.17 Million AUD | 0.0% |
| 2021 FY | 1.17 Million AUD | 26.44% |
| 2021 Q2 | 1.39 Million AUD | 0.0% |
| 2020 Q4 | 931.52 Thousand AUD | 0.0% |
| 2020 FY | 931.52 Thousand AUD | -29.84% |
| 2020 Q2 | 698.74 Thousand AUD | 0.0% |
| 2019 Q2 | 902.54 Thousand AUD | 0.0% |
| 2019 FY | 1.32 Million AUD | 195.84% |
| 2019 Q4 | 1.32 Million AUD | 0.0% |
| 2018 Q4 | 448.82 Thousand AUD | 0.0% |
| 2018 FY | 448.82 Thousand AUD | -48.67% |
| 2018 Q2 | 738.74 Thousand AUD | 0.0% |
| 2017 FY | 874.44 Thousand AUD | 322.85% |
| 2017 Q4 | 874.44 Thousand AUD | 0.0% |
| 2017 Q2 | 243.94 Thousand AUD | 0.0% |
| 2016 Q4 | 195.06 Thousand AUD | 0.0% |
| 2016 Q2 | 514.29 Thousand AUD | 0.0% |
| 2016 FY | 206.79 Thousand AUD | -24.1% |
| 2015 Q4 | 265.78 Thousand AUD | 0.0% |
| 2015 FY | 272.47 Thousand AUD | 33.69% |
| 2015 Q3 | 265.78 Thousand AUD | 0.0% |
| 2014 FY | 203.8 Thousand AUD | 31.86% |
| 2013 FY | 154.56 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | -348.642% |
| Biome Australia Limited | 5.37 Million AUD | -195.786% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 64.431% |
| Biotron Limited | 737.5 Thousand AUD | -2055.012% |
| Acrux Limited | 5.68 Million AUD | -179.469% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -192.929% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -325.859% |
| BTC Health Limited | 203.94 Thousand AUD | -7692.861% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -24.137% |
| CSL Limited | 27.88 Billion AUD | 99.943% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -90.757% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 43.464% |
| Immutep Limited | 10.97 Million AUD | -44.754% |
| Memphasys Limited | 5.59 Million AUD | -184.197% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 62.834% |
| Noxopharm Limited | 1.28 Million AUD | -1133.37% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -583.421% |
| Race Oncology Limited | 1.91 Million AUD | -729.325% |
| Starpharma Holdings Limited | 8.69 Million AUD | -82.725% |
| Tissue Repair Ltd | 1.35 Million AUD | -1076.5% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -275.806% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -5079.546% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -4213.626% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -69.863% |
| Patrys Limited | 691.36 Thousand AUD | -2198.841% |
| Orthocell Limited | 22.08 Million AUD | 28.028% |
| Imugene Limited | 33.14 Million AUD | 52.047% |
| PYC Therapeutics Limited | 10.18 Million AUD | -56.061% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -877.498% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -1257.185% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -672.785% |
| Nanollose Limited | 465.64 Thousand AUD | -3313.212% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -3582.178% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -18449.052% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -363.797% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -1419.99% |
| Nyrada Inc. | 855.63 Thousand AUD | -1757.5% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 93.627% |
| Dimerix Limited | 13.89 Million AUD | -14.398% |
| PharmAust Limited | 896.6 Thousand AUD | -1672.614% |
| Hexima Limited | 248.67 Thousand AUD | -6291.356% |
| AnteoTech Limited | 4.07 Million AUD | -289.997% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -343.412% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -1588.02% |
| Actinogen Medical Limited | 1.61 Million AUD | -883.886% |
| Immuron Limited | 2.84 Million AUD | -459.523% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -554.933% |